首页 | 本学科首页   官方微博 | 高级检索  
检索        

尼麦角林治疗多发梗死性痴呆临床观察
引用本文:陈运平,梅元武,程世庆.尼麦角林治疗多发梗死性痴呆临床观察[J].医药导报,2002,21(12):777-778.
作者姓名:陈运平  梅元武  程世庆
作者单位:华中科技大学同济医学院附属协和医院神经内科,武汉,430022
摘    要:目的;观察尼麦角林对多发梗死性痴呆认知功能障碍的疗效.方法;32例多发梗死性痴呆患者均口服尼麦角林10 mg,tid,连服3个月为1疗程.结果;多发梗死性痴呆患者认知功能MMSE评分治疗后较治疗前显著提高(P<0.01),认知功能改善的总有效率84.4%.结论;尼麦角林对改善多发梗死性痴呆认知功能障碍具有较好的疗效.

关 键 词:尼麦角林  痴呆  多发梗死性  认知功能
文章编号:1004-0781(2002)12-0777-02
修稿时间:2001年6月28日

A Clinical Observation on the Effect of Nicergoline in the Treatment of Multi-infarct Dementia
CHEN Yun ping,MEI Yuan wu,CHENG Shi qing.A Clinical Observation on the Effect of Nicergoline in the Treatment of Multi-infarct Dementia[J].Herald of Medicine,2002,21(12):777-778.
Authors:CHEN Yun ping  MEI Yuan wu  CHENG Shi qing
Abstract:Objective:To survey the therapeutic effect of nicergoline (Sermion) on the disorder of cognitive function in patients with multi infarct dementia (MID). Method:32 patients with MID were given each nicengoline at a dosage of 10 mg t.i.d. per os for 3 consecutive months. Results:The mean MMSE score reflecting the cognitive function of the patients with MID was significantly increased ( P <0.01) after nicergoline treatment, as compared with that before the treatment. The total effective rate was 84.4%. Conclusion:Nicergoline was shown to be an effective drug for improving the cognitive function of patients with MID.
Keywords:Nicergoline  Multi  infarct dementia  Cognitive function
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《医药导报》浏览原始摘要信息
点击此处可从《医药导报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号